| Quarterly Financials | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 203 | 224 | 231 | 246 | 248 | 267 | 281 | 302 | 296 | 343 | 340 | 344 | 366 | 405 | 375 | 399 |
| Expenses | 151 | 166 | 183 | 193 | 192 | 203 | 211 | 228 | 223 | 257 | 257 | 257 | 275 | 301 | 288 | 299 |
| EBITDA | 51 | 58 | 48 | 53 | 57 | 64 | 70 | 74 | 72 | 86 | 84 | 87 | 91 | 104 | 86 | 100 |
| Operating Profit % | 25 % | 25 % | 20 % | 20 % | 21 % | 23 % | 23 % | 22 % | 23 % | 23 % | 23 % | 24 % | 22 % | 23 % | 21 % | 23 % |
| Depreciation | 9 | 10 | 10 | 10 | 11 | 11 | 11 | 10 | 11 | 14 | 14 | 18 | 21 | 22 | 22 | 23 |
| Interest | 10 | 10 | 11 | 11 | 12 | 12 | 1 | 1 | 1 | 1 | 3 | 6 | 8 | 8 | 8 | 9 |
| Profit Before Tax | 32 | 38 | 27 | 32 | 34 | 41 | 58 | 62 | 60 | 70 | 67 | 63 | 62 | 74 | 57 | 68 |
| Tax | 2 | 11 | 27 | 16 | -20 | 8 | 14 | 17 | 16 | 18 | 15 | 18 | 18 | 17 | 14 | 17 |
| Net Profit | 31 | 27 | -0 | 16 | 54 | 34 | 44 | 45 | 45 | 52 | 52 | 45 | 44 | 58 | 43 | 50 |
| EPS in ₹ | 5.99 | 5.32 | -0.12 | 3.04 | 9.93 | 5.67 | 6.56 | 6.49 | 6.80 | 7.88 | 7.95 | 6.84 | 6.69 | 8.75 | 6.49 | 7.66 |
Jupiter Life Line Hospital
Jupiter Life Line Hospital
1,314.60
+9.30
(0.71%)
Market Cap
8,619.31 Cr
PE Ratio
43.93
Volume
25,102.00
Day High - Low
1,340.00 - 1,280.40
52W High-Low
1,625.00 - 1,178.00
Key Fundamentals
Market Cap
8,619.31 Cr
EPS
29.59
PE Ratio
43.93
PB Ratio
5.53
Book Value
235.50
EBITDA
338.37
Dividend Yield
0.08 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
14.27
Debt to Equity
0.16
Analyst Rating and Forecast
- By Refinitiv from5 analysts
Actual
Company News
View All News
Jupiter Life Line Hospitals posts Q4FY26 consolidated revenue of Rs 371.7 cr (+15.1% YoY), PAT of Rs 50.2 cr; board approves 1:5 share split, Rs 1 interim dividend, and key management changes.
Jupiter Life Line Hospitals has released the audio recording of its Q4 & FY26 analyst/investor conference call held on May 18, 2026, now available on the company website.
Sivasish Sen resigns as CFO of Jupiter Life Line Hospitals Limited and its material subsidiary Jupiter Hospital Projects Private Limited, effective May 31, 2026, citing personal commitments.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
8,089.50 | #1 1,16,314.60 | 58.15 | #1 25,228.50 | 14.70 | #1 2,032 | 33.00 | 53.73 | |
948.70 | 92,321.32 | 63.33 | 8,373.45 | 16.56 | 1,464 | 7.27 | 35.49 | |
929.40 | 70,165.81 | 65.88 | 9,127.84 | 16.28 | 1,064 | 44.26 | 45.61 | |
1,934.20 | 39,527.47 | 48.28 | 7,896.04 | #1 41.63 | 788 | 13.53 | 59.39 | |
726.95 | 37,664.81 | 87.52 | 4,643.22 | 8.32 | 384 | #1 79.65 | 49.10 | |
1,198.80 | 32,222.59 | 56.69 | 4,410.27 | 16.94 | 584 | 39.64 | 52.67 | |
746.40 | 29,866.37 | 124.56 | 3,904.60 | 27.31 | 198 | -68.80 | 53.48 | |
476.55 | 15,097.46 | 90.68 | 2,080.08 | 18.39 | 168 | 17.65 | 60.42 | |
1,341.40 | 13,623.15 | 49.24 | 1,703.08 | 8.69 | 262 | 38.41 | 56.65 | |
282.65 | 12,208.53 | #1 43.29 | 1,679.36 | 17.77 | 272 | 46.56 | 67.75 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
16.24 %
Net Income Growth
1.65 %
Cash Flow Change
121.18 %
ROE
-5.56 %
ROCE
-18.82 %
EBITDA Margin (Avg.)
-12.97 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 603 | 789 | 909 | 986 | 1,281 | 1,905 | 2,383 |
| Fixed Assets | 435 | 630 | 684 | 720 | 718 | 977 | 1,513 |
| Current Assets | 134 | 113 | 180 | 209 | 410 | 687 | 685 |
| Capital Work in Progress | 11 | 26 | 27 | 29 | 74 | 185 | 129 |
| Investments | 2 | 7 | 3 | 2 | 17 | 114 | 38 |
| Other Assets | 156 | 126 | 195 | 235 | 473 | 628 | 0 |
| Total Equity & Liabilities | 603 | 789 | 909 | 986 | 1,281 | 1,905 | 2,383 |
| Current Liabilities | 103 | 96 | 123 | 132 | 106 | 152 | 227 |
| Non Current Liabilities | 263 | 447 | 497 | 490 | 7 | 396 | 613 |
| Total Equity | 237 | 246 | 288 | 364 | 1,169 | 1,356 | 1,544 |
| Reserve & Surplus | 186 | 188 | 241 | 309 | 1,104 | 1,291 | 1,479 |
| Share Capital | 51 | 51 | 51 | 57 | 66 | 66 | 66 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | 13 | 85 | 31 | -4 | 345 |
| Investing Activities | -43 | -295 | -84 | -94 | -246 | -209 |
| Operating Activities | 74 | 123 | 137 | 176 | 115 | 253 |
| Financing Activities | -32 | 184 | 32 | -51 | 128 | 301 |
Share Holding
| % Holding | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 40.91 % | 40.91 % | 40.91 % | 40.91 % | 40.91 % | 40.91 % | 40.91 % | 40.91 % | 40.91 % | 40.91 % | 40.91 % |
| FIIs | 0.00 % | 0.00 % | 4.17 % | 6.06 % | 8.84 % | 10.04 % | 10.03 % | 9.77 % | 9.06 % | 8.48 % | 8.48 % |
| DIIs | 12.33 % | 13.59 % | 17.58 % | 17.27 % | 16.87 % | 15.74 % | 15.63 % | 15.82 % | 16.95 % | 17.43 % | 17.01 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 29.91 % | 28.01 % | 27.78 % | 26.31 % | 24.39 % | 24.45 % | 24.54 % | 24.64 % | 24.37 % | 24.36 % | 24.52 % |
| Others | 16.85 % | 17.49 % | 9.56 % | 9.45 % | 8.98 % | 8.85 % | 8.88 % | 8.86 % | 8.70 % | 8.82 % | 9.08 % |
| No of Share Holders | 2,13,467 | 39,348 | 35,107 | 35,797 | 34,081 | 33,914 | 33,956 | 34,192 | 34,361 | 33,620 | 32,985 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.08 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 02 Aug 2024 |  Dividend | ₹ 1.00 /share | 02 Aug 2024 | 1,221.50 | 1,333.65 |
| 09 Aug 2024 |  Annual General Meeting | NA | 09 Aug 2024 | 1,329.30 | 1,312.80 |
| 08 Nov 2024 |  Quarterly Result Announcement | NA | 08 Nov 2024 | 1,361.05 | 1,385.90 |
| 07 Feb 2025 | Quarterly Result Announcement | NA | 07 Feb 2025 | 1,602.85 | 1,663.05 |
| 09 May 2025 | Quarterly Result Announcement | NA | 09 May 2025 | 1,459.25 | 1,453.45 |
| 04 Jul 2025 | Dividend | ₹ 1.00 /share | 04 Jul 2025 | 1,453.45 | 1,490.00 |
| 11 Jul 2025 | Annual General Meeting | NA | 11 Jul 2025 | 1,543.00 | 1,507.20 |
| 01 Aug 2025 | Quarterly Result Announcement | NA | 01 Aug 2025 | 1,460.50 | 1,432.00 |
| 07 Nov 2025 | Quarterly Result Announcement | NA | 07 Nov 2025 | 1,586.75 | 1,553.60 |
| 30 Jan 2026 | Quarterly Result Announcement | NA | 30 Jan 2026 | 1,335.60 | 1,292.85 |
| 15 May 2026 | Quarterly Result Announcement | NA | 15 May 2026 | 1,249.40 | 1,326.50 |
| 22 May 2026 | Dividend | ₹ 1.00 /share | 22 May 2026 | 1,326.50 | 1,312.00 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
May 21, 2026
May 21, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 18, 2026
May 18, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorMay 18, 2026
May 18, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 18, 2026
May 18, 2026Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)May 18, 2026
May 18, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 17, 2026
May 17, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 15, 2026
May 15, 2026Corporate Action-Intimation of Sub division / Stock SplitMay 15, 2026
May 15, 2026Declaration Of Interim DividendMay 15, 2026
May 15, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 15, 2026
May 15, 2026Outcome Of Board Meeting Dated May 15 2026May 15, 2026
May 15, 2026Board Meeting Outcome for Outcome Of Board Meeting Dated May 15 2026May 15, 2026
May 15, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorMay 15, 2026
May 15, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 11, 2026
May 11, 2026Board Meeting Intimation for Pior Intimation Of The Board Meeting To Be Held On Friday May 15 2026May 11, 2026
May 11, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011May 06, 2026
May 06, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2026
Apr 03, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMar 27, 2026
Mar 27, 2026Closure of Trading WindowMar 25, 2026
Mar 25, 2026Announcement under Regulation 30 (LODR)-Credit RatingMar 10, 2026
Mar 10, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2026
Feb 27, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 18, 2026
Feb 18, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 04, 2026
Feb 04, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 02, 2026
Feb 02, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 01, 2026
Feb 01, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJan 31, 2026
Jan 31, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJan 30, 2026
Jan 30, 2026Commencement Of Operations At Jupiter Hospital Dombivli Mumbai Metropolitan Region.Jan 30, 2026
Jan 30, 2026Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Jan 30, 2026
Jan 30, 2026Board Meeting Outcome for Outcome Of Board Meeting Dated January 30 2026Jan 30, 2026
Jan 30, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 23, 2026
Jan 23, 2026Board Meeting Intimation for Prior Intimation Of The Board Meeting To Be Held On Friday January 30 2026Jan 23, 2026
Jan 23, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Closure of Trading WindowDec 24, 2025
Dec 24, 2025Announcement under Regulation 30 (LODR)-RestructuringNov 18, 2025
Nov 18, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 13, 2025
Nov 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 10, 2025
Nov 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 09, 2025
Nov 09, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 07, 2025
Nov 07, 2025Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2025Nov 07, 2025
Nov 07, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated November 07 2025Nov 07, 2025
Nov 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 04, 2025
Nov 04, 2025Board Meeting Intimation for Prior Intimation Of The Board Meeting To Be Held On Friday November 07 2025Nov 02, 2025
Nov 02, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 01, 2025
Nov 01, 2025Clarification Regarding The News ArticleOct 13, 2025
Oct 13, 2025Clarification sought from Jupiter Life Line Hospitals LtdOct 13, 2025
Oct 13, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 51.75
ATR(14)
Less Volatile 45.86
STOCH(9,6)
Neutral 52.56
STOCH RSI(14)
Neutral 51.33
MACD(12,26)
Bullish 0.39
ADX(14)
Weak Trend 15.90
UO(9)
Bearish 41.60
ROC(12)
Uptrend And Accelerating 2.76
WillR(14)
Neutral -52.70
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
